Celon Pharma S.A.
WSE:CLN.WA
15.96 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 32.359 | 82.902 | 147.796 | 43.978 | 66.692 | 147.998 | 200.945 | 220.424 | 2.564 | 0.057 | 5.683 | 5.95 |
| Short Term Investments
| 82.184 | 81.722 | 79.755 | 0.013 | -0.091 | 54.476 | -0.091 | 1.438 | 0.633 | 0.59 | 0.176 | 0.15 |
| Cash and Short Term Investments
| 114.543 | 164.624 | 227.551 | 43.978 | 66.692 | 147.998 | 200.945 | 221.862 | 3.196 | 0.647 | 5.859 | 6.1 |
| Net Receivables
| 32.789 | 33.701 | 24.674 | 42.021 | 39.177 | 39.767 | 0 | 25.508 | 21.312 | 18.691 | 10.149 | 0 |
| Inventory
| 25.747 | 38.385 | 23.373 | 27.813 | 30.062 | 23.607 | 18.048 | 19.869 | 19.491 | 7.473 | 9.57 | 4.175 |
| Other Current Assets
| 16.67 | 0.871 | 3.103 | 16.121 | 7.645 | 42.51 | 0 | 2.923 | 0.947 | 2.234 | 1.218 | 0 |
| Total Current Assets
| 189.749 | 237.581 | 278.701 | 118.917 | 143.576 | 213.751 | 254.546 | 270.162 | 44.946 | 29.045 | 26.796 | 17.57 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 333.799 | 306.794 | 329.208 | 329.141 | 242.785 | 190.716 | 134.762 | 112.076 | 100.508 | 54.415 | 37.922 | 38.472 |
| Goodwill
| 0 | -5.324 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 14.974 | 28.121 | 29.171 | 41.095 | 6.162 | 7.41 | 2.639 | 3.357 | 2.973 | 0.905 | 0.408 | 0.48 |
| Goodwill and Intangible Assets
| 14.974 | 22.797 | 29.171 | 41.095 | 6.162 | 7.41 | 2.639 | 3.357 | 2.973 | 0.905 | 0.408 | 0.48 |
| Long Term Investments
| -70.769 | -68.477 | -41.634 | 12.965 | 48.621 | 0 | 70.819 | 45.364 | 5.925 | 6.558 | 2.59 | 1.848 |
| Tax Assets
| 19.053 | 28.139 | 31.937 | 22.504 | 11.497 | 7.41 | 7.408 | 6.957 | 7.255 | 0 | 0 | 0 |
| Other Non-Current Assets
| 82.502 | 82.101 | 79.755 | 179.02 | 138.705 | 144.381 | 54.876 | 26.406 | 6.682 | 14.513 | 14.876 | -40.8 |
| Total Non-Current Assets
| 379.559 | 371.354 | 428.437 | 584.725 | 447.77 | 349.917 | 270.504 | 194.159 | 123.343 | 76.39 | 55.796 | 40.8 |
| Total Assets
| 569.308 | 608.935 | 707.138 | 703.642 | 591.346 | 563.668 | 525.05 | 464.321 | 168.289 | 105.435 | 82.591 | 69.798 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 10.505 | 17.473 | 11.872 | 18.417 | 7.363 | 9.004 | 5.928 | 5.859 | 13.866 | 5.225 | 4.46 | 4.04 |
| Short Term Debt
| 19.88 | 19.434 | -3.599 | 16.323 | 1.466 | 0 | 1.6 | 3.208 | 11.983 | 3.694 | 1.197 | 0 |
| Tax Payables
| 0 | 0 | 0 | 1.226 | 1.02 | 0.644 | 1.719 | 0.52 | 1.45 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 10.162 | 11.108 | -1.466 | 0.644 | 7.252 | 4.958 | 7.16 | 0 | 0 | 0 |
| Other Current Liabilities
| 55.952 | 79.533 | 57.766 | 78.18 | 16.134 | 10.069 | 2.474 | -0.302 | -1.817 | 9.383 | 5.026 | 10.185 |
| Total Current Liabilities
| 86.337 | 116.44 | 86.363 | 70.57 | 25.983 | 19.717 | 18.972 | 14.243 | 36.552 | 18.302 | 10.683 | 14.225 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| -17.174 | 7.388 | 8.354 | 9.158 | 0.194 | 0 | 1.707 | 3.039 | 3.674 | 1.485 | 2.199 | 0 |
| Deferred Revenue Non-Current
| 22.884 | 0 | 29.851 | 0 | -0.194 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 3.011 | 1.315 | 6.042 | 16.465 | 11.514 | 12.741 | 14.379 | 8.961 | 1.407 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.81 | 4.146 | 22.526 | 64.05 | 120.128 | 82.48 | 50.144 | 35.577 | 25.837 | 16.029 | 17.507 | 0 |
| Total Non-Current Liabilities
| 37.415 | 12.849 | 66.773 | 198.401 | 120.322 | 95.222 | 66.23 | 47.576 | 30.919 | 17.514 | 19.706 | 0 |
| Total Liabilities
| 123.752 | 129.289 | 153.136 | 268.971 | 146.305 | 114.939 | 85.203 | 61.82 | 67.471 | 35.816 | 30.389 | 14.225 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 5.106 | 5.104 | 5.1 | 3 | 4.5 | 4.5 | 4.5 | 4.5 | 3 | 3 | 3 | 3 |
| Retained Earnings
| -108.635 | -119.788 | -91.674 | 31.565 | 22.005 | 39.767 | 35.685 | 47.877 | 44.68 | 66.619 | 49.202 | 33.035 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 594.33 | 640.576 | 398.606 | 184.084 | 170.011 | 399.662 | 350.124 | 53.137 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 549.085 | 587.104 | 613.51 | 393.124 | 384.788 | 234.452 | 347.926 | 317.769 | 53.137 | 0 | 0 | -36.035 |
| Total Shareholders Equity
| 445.556 | 479.646 | 554.002 | 434.671 | 445.04 | 448.729 | 439.847 | 402.501 | 100.817 | 69.619 | 52.202 | 36.035 |
| Total Equity
| 445.556 | 479.646 | 554.002 | 434.671 | 445.04 | 448.729 | 439.847 | 402.501 | 100.817 | 69.619 | 52.202 | 36.035 |
| Total Liabilities & Shareholders Equity
| 569.308 | 608.935 | 707.138 | 703.642 | 591.346 | 563.668 | 525.05 | 464.321 | 168.289 | 105.435 | 82.591 | 0 |